Skip to main content
Frontiers in Aging Neuroscience logoLink to Frontiers in Aging Neuroscience
. 2019 Nov 8;11:292. doi: 10.3389/fnagi.2019.00292

Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects

Lih-Fen Lue 1, Ming-Chyi Pai 2, Ta-Fu Chen 3, Chaur-Jong Hu 4,5, Li-Kai Huang 4,5, Wei-Che Lin 6, Chau-Chung Wu 7, Jian-Shing Jeng 3, Kaj Blennow 8,9, Marwan N Sabbagh 10, Sui-Hing Yan 11, Pei-Ning Wang 12,13, Shieh-Yueh Yang 14,15, Hiroyuki Hatsuta 16,17, Satoru Morimoto 16,18, Akitoshi Takeda 17, Yoshiaki Itoh 17, Jun Liu 19, Haiqun Xie 20, Ming-Jang Chiu 3,*
PMCID: PMC6856676  PMID: 31754353

In the original article, there was an error. The name of a participating site was incorrectly written as “Keio University Hospital.” The correct site is “Hatsuta Neurology Clinic.”

A correction has therefore been made to the table and legend for Table 1:

Table 1.

The means and standard deviations (SD) of age (years) of the normal-cognition subjects in each participating site*.

Site no. Name of sites Subject no. Median (years) Minimum (years) Maximum (years) Age, years Mean ± S.D.
1 NTUH-1 90 57 23 81 53.60 ± 17.91
2 NTUH-2 79 69 56 89 70.35 ± 8.12
3 NTUH-3 24 46 26 89 49.54 ± 18.41
4 NCKUH 48 54 33 70 54.15 ± 7.49
5 SHH 38 65 56 76 64.97 ± 5.63
6 KCGMH 27 60 50 72 61.15 ± 4.93
7 SU 18 71 53 89 70.50 ± 9.60
8 BSHRI 16 82 71 91 81.94 ± 5.99
9 RAH 11 64 58 74 64.91 ± 5.05
10 TVGH 17 60 54 88 64.06 ± 10.23
11 SYSH 9 66 45 79 62.67 ± 10.25
12 HNC/ OCUH 14 65 53 83 64.93 ± 7.21
*

Normal cognition: CDR = 0, MMSE: 28–30, and meet NIA-AA guidelines published in 2011.

Name of sites: NTUH, National Taiwan University Hospital; NCKUH, National Cheng Kung University Hospital; SHH, Shuang Ho Hospital; KCGMH, Kaohsiung Chang Gung Memorial Hospital; SUH, Sahlgrenska University Hospital; BSHRI, Banner Sun Health Research Institute; RAH, Renai Branch Taipei City Hospital; TVGHL, Taipei Veterans General Hospital; SYSMH, Sun Yet-Sen Memory Hospital; FH, Foshan Hospital; HNC, Hatsuta Neurology Clinic; OCUH, Osaka City University; SD, standard deviation.

Additionally, a correction has also been made to the Materials and Methods section, subsection Participating Sites:

“A total of 391 cognitively normal subjects aged 23–91 were enrolled from 2010 to 2018 from the following six hospitals in Taiwan: National Taiwan University Hospital (NTUH), Taipei Medical University Shuang-Ho Hospital (SHH), Renai Branch of Taipei City Hospital (RAH), Taipei Veterans General Hospital (TVGH), National Cheng Kung University Hospital (NCKUH), and Kaohsiung Chang Gung Memorial Hospital (KCGMH); Sahlgrenska University Hospital (SUH) in Guttenberg, Sweden; Banner Sun Health Research Institute (BSHRI) in Sun City, AZ, USA; two hospitals in the cities of Foshan, Foshan Hospital (FH) and Guangzhou, Sun Yat-Sen Memorial Hospital (SYSMH), Guangdong, China; and finally two hospitals in Japan: Hatsuta Neurology Clinic (HNC) in Osaka, and Osaka City University Hospital (OCUH) in Osaka. All participants were older than 21 years of age and gave their own written informed consent. The study was approved by the Institutional Review Board (IRB) or Research Ethics Committee (REC) of each participating hospital in the respective countries, namely, NTUH REC, Taipei Medical University-Joint IRB for SHH, Taipei City Hospital REC for RAH, TVGH IRB, NCKUH IRB, KCGMH IRB, Central Ethical Review Board-University of Gothenburg for SUH, Banner Health IRB for BSHRI, Sun Yat-Sen University Hospital (SYSUH) Cancer Center IRB, Asai Dermatology Clinic IRB and Osaka City University IRB.”

And the subsection Cognition Assessment and Criteria for Recruitment:

“The purpose of the recruitment criteria was to exclude subjects with diagnoses of MCI and dementia. All study sites followed the NIA-AA criteria for the diagnosis of dementia and MCI due to AD (Albert et al., 2011; McKhann et al., 2011). In addition to clinical criteria, basic cognitive assessment tools [Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR)] were also used. The criteria for normal cognition were MMSE ≥ 28 and CDR = 0. Brain imaging and CSF biomarkers were used as supplementary tools. Brain (FDG)-PET were used by HNC/OCUH, Japan, and Subjects from SUH, Sweden had CSF Ab > 530 pg/ml and t-Tau <350 pg/ml (Sutphen et al., 2015; Teunissen et al., 2018). Subjects who had acute or chronic systemic diseases or neuropsychiatric disorders, visual or auditory dysfunction severe enough to interfere with cognitive assessments were all excluded.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

References

  1. Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. McKhann G. M., Knopman D. S., Chertkow H., Hyman B. T., Jack C. R., Jr., Kawas C. H., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263–269. 10.1016/j.jalz.2011.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Sutphen C. L., Jasielec M. S., Shah A. R., Macy E. M., Xiong C., Vlassenko A. G., et al. (2015). Longitudinal cerebrospinal fluid biomarker changes inpreclinical Alzheimer disease during middle age. JAMA Neurol. 72, 1029–1042. 10.1001/jamaneurol.2015.1285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Teunissen C. E., Chiu M. J., Yang C. C., Yang S. Y., Scheltens P., Zetterberg H., et al. (2018). Plasma Amyloid-β (Aβ42) correlates with cerebrospinal fluid Aβ42 in Alzheimer's disease. J. Alzheimers Dis. 62, 1857–1863. 10.3233/JAD-170784 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Aging Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES